B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20

Neuromyelitis optica spectrum disorder (NMOSD) is a rare relapsing autoimmune disease of the central nervous system that preferentially targets the optic nerves and spinal cord, leading to visual loss and impaired mobility. Until 2019, no medications were FDA-approved for NMOSD treatment, and standa...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Michael, Mealy, Maureen A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384424/
https://www.ncbi.nlm.nih.gov/pubmed/34447723
http://dx.doi.org/10.2147/ITT.S255722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384424/
https://www.ncbi.nlm.nih.gov/pubmed/34447723
http://dx.doi.org/10.2147/ITT.S255722

Ejemplares similares